Mid
Z
ZLABAI Stock Diagnostic Report
Zai Lab receives Orphan Drug status for ADC for neuroendocrine carcinomas
Zai Lab has received Orphan Drug designation for its ADC for the treatment of neuroendocrine tumors.
View Source Article ↗
AI CATALYST SCORE75 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
ZLAB Analysis History (Last 30 Days)